Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.

[1]  Shuhui Wei,et al.  A review of arsenic exposure and lung cancer. , 2019, Toxicology research.

[2]  G. Lai,et al.  Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells. , 2019, Experimental and therapeutic medicine.

[3]  J. Cowden,et al.  Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties , 2017, Journal of Exposure Science and Environmental Epidemiology.

[4]  E. Llop,et al.  Human adaptation to arsenic in Andean populations of the Atacama Desert. , 2017, American journal of physical anthropology.

[5]  B. Clin,et al.  Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort , 2017, International Archives of Occupational and Environmental Health.

[6]  Wei-Cheng Lo,et al.  Incidence and survival of adult cancer patients in Taiwan, 2002-2012. , 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

[7]  M. Mendez,et al.  Association Between Variants in Arsenic (+3 Oxidation State) Methyltranserase (AS3MT) and Urinary Metabolites of Inorganic Arsenic: Role of Exposure Level. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  R. E. Bowen,et al.  Association of Cardiometabolic Genes with Arsenic Metabolism Biomarkers in American Indian Communities: The Strong Heart Family Study (SHFS) , 2016, Environmental health perspectives.

[9]  F. Zou,et al.  Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis. , 2016, Reproductive toxicology.

[10]  Lucie M. Gattepaille,et al.  Human adaptation to arsenic-rich environments. , 2015, Molecular biology and evolution.

[11]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[12]  W. Goessler,et al.  Genetic Variation in Arsenic (+3 Oxidation State) Methyltransferase (AS3MT), Arsenic Metabolism and Risk of Basal Cell Carcinoma in a European Population , 2014, Environmental and molecular mutagenesis.

[13]  J. Cowden,et al.  AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility. , 2014, Environmental research.

[14]  Fen Wu,et al.  Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh. , 2014, Toxicology and applied pharmacology.

[15]  D. Loomis,et al.  Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico , 2013, Journal of Exposure Science and Environmental Epidemiology.

[16]  E. Guallar,et al.  Heritability and Preliminary Genome-Wide Linkage Analysis of Arsenic Metabolites in Urine , 2013, Environmental health perspectives.

[17]  Chien-Jen Chen,et al.  Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan. , 2012, Chemosphere.

[18]  K. Cooney,et al.  Genetic variation in Glutathione S-Transferase Omega-1, Arsenic Methyltransferase and Methylene-tetrahydrofolate Reductase, arsenic exposure and bladder cancer: a case–control study , 2012, Environmental Health.

[19]  Arthur P. Grollman,et al.  Aristolochic acid-associated urothelial cancer in Taiwan , 2012, Proceedings of the National Academy of Sciences.

[20]  C. Marsit,et al.  A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. , 2012, Toxicology letters.

[21]  J. Baron,et al.  Genome-Wide Association Study Identifies Chromosome 10q24.32 Variants Associated with Arsenic Metabolism and Toxicity Phenotypes in Bangladesh , 2012, PLoS genetics.

[22]  K. Bensalah,et al.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas , 2011, World Journal of Urology.

[23]  T. Agusa,et al.  Individual Variations in Inorganic Arsenic Metabolism Associated with AS3MT Genetic Polymorphisms , 2011, International journal of molecular sciences.

[24]  M. Vahter,et al.  Polymorphisms in Arsenic(+III Oxidation State) Methyltransferase (AS3MT) Predict Gene Expression of AS3MT as Well as Arsenic Metabolism , 2010, Environmental health perspectives.

[25]  A. Ouzzane,et al.  Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract , 2009, BJU international.

[26]  L. D. Del Razo,et al.  Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. , 2009, Toxicology and applied pharmacology.

[27]  T. Yasuda,et al.  DIVERSITY OF GLUTATHIONE S‐TRANSFERASE OMEGA 1 (A140D) AND 2 (N142D) GENE POLYMORPHISMS IN WORLDWIDE POPULATIONS , 2009, Clinical and experimental pharmacology & physiology.

[28]  Kow-Tong Chen,et al.  Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan , 2008, BJU international.

[29]  Y. Hsueh,et al.  Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study , 2008, Cancer Causes & Control.

[30]  Y. Hsueh,et al.  Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  Y. Hsueh,et al.  Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. , 2007, Toxicology and applied pharmacology.

[32]  A. Puga,et al.  Long term low-dose arsenic exposure induces loss of DNA methylation. , 2007, Biochemical and biophysical research communications.

[33]  S. Waters,et al.  Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals , 2007, Experimental biology and medicine.

[34]  Thomas Brambor,et al.  Understanding Interaction Models: Improving Empirical Analyses , 2006, Political Analysis.

[35]  M. Stýblo,et al.  shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. , 2006, Chemical research in toxicology.

[36]  Y. Hsueh,et al.  Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. , 2005, Toxicology and applied pharmacology.

[37]  R. Sylvester,et al.  EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. , 2004, European urology.

[38]  Thomas J. Smith,et al.  Arsenic methylation and bladder cancer risk in Taiwan , 2003, Cancer Causes & Control.

[39]  Thomas J. Smith,et al.  Arsenic Methylation and Skin Cancer Risk in Southwestern Taiwan , 2003, Journal of occupational and environmental medicine.

[40]  M. Vahter.  Mechanisms of arsenic biotransformation. , 2002, Toxicology.

[41]  Y. Hsueh,et al.  Stability of arsenic species and insoluble arsenic in human urine. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  I. Jaspers,et al.  The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. , 2002, Environmental health perspectives.

[43]  Jin-Hwang Liu,et al.  Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. , 2002, Urology.

[44]  T. Radabaugh,et al.  Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. , 2002, Chemical research in toxicology.

[45]  D. Liebler,et al.  Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. , 2001, Chemical research in toxicology.

[46]  Y. Chou,et al.  Unusual clinical presentation of upper urothelial carcinoma in Taiwan , 1999, Cancer.

[47]  Y. Hsueh,et al.  Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. , 1998, Journal of toxicology and environmental health. Part A.

[48]  Y. Hsueh,et al.  Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. , 1995, Cancer research.

[49]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[50]  D. Aga,et al.  Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  Dianjun Sun,et al.  Urinary arsenic metabolism in a Western Chinese population exposed to high-dose inorganic arsenic in drinking water: influence of ethnicity and genetic polymorphisms. , 2014, Toxicology and applied pharmacology.

[52]  Y. Hsueh,et al.  Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. , 2011, The Science of the total environment.

[53]  C. Marsit,et al.  Carcinogen exposure and gene promoter hypermethylation in bladder cancer. , 2006, Carcinogenesis.